Effect of a potent cyclooxygenase inhibitor, 5-ethyl-4-methoxy-2-phenylquinoline (KTC-5), on human platelets (original) (raw)
Investigation of cyclooxygenase and signaling pathways involved in human platelet aggregation mediated by synergistic interaction of various agonists
Bassem S H A B A N Sadek
Drug Design, Development and Therapy, 2015
View PDFchevron_right
Measurement of arachidonic acid liberation in thrombin-stimulated human platelets. Use of agents that inhibit both the cyclooxygenase and lipoxygenase enzymes
Gerard Mauco
Biochimica et biophysica acta, 1985
View PDFchevron_right
Role of arachidonic acid metabolism in human platelet activation and irreversible aggregation
Gundu Rao
American Journal of Hematology, 1985
View PDFchevron_right
Inhibition of cyclooxygenase-independent platelet aggregation by low vitamin E concentration
Luigi Iuliano
Atherosclerosis, 1990
View PDFchevron_right
Rapid inactivation of cyclooxygenase activity after stimulation of intact platelets
Eduardo Lapetina
Proceedings of the National Academy of Sciences, 1979
View PDFchevron_right
A role for cyclooxygenase products in the formation of phosphatidic acid in stimulated human platelets. Differential mechanisms of action of thrombin and collagen
W. Siess
The Journal of biological chemistry, 1983
View PDFchevron_right
Pharmacologic Inhibition of Thromboxane Synthetase and Platelet Aggregation: Modulatory Role of Cyclooxygenase Products
giovanni de gaetano
1984
View PDFchevron_right
Multifaceted effects of arachidonic acid and interaction with cyclic nucleotides in human platelets
Valentina Shpakova
Thrombosis Research, 2018
View PDFchevron_right
Inhibition by sulfhydryl agents of arachidonic acid-induced platelet aggregation and release of potential inflammatory substances
Bernardo Vargaftig
Prostaglandins, 1974
View PDFchevron_right
New analogues of 13-hydroxyocatdecadienoic acid and 12-hydroxyeicosatetraenoic acid block human blood platelet aggregation and cyclooxygenase-1 activity
Ali Khalaf
Chemistry Central Journal, 2012
View PDFchevron_right
Effects on primary haemostasis of an anti-inflammatory agent with 5-lipoxygenase and cyclooxygenase inhibitory activity
Maria Valentina Perez Hernandez
Journal of cardiovascular medicine (Hagerstown, Md.), 2006
View PDFchevron_right
Structural requirements for preventing the aspirin- and the arachidonate-induced inactivation of platelet cyclo-oxygenase: Additional evidence for distinct enzymatic sites
Bernardo Vargaftig
European Journal of Pharmacology, 1984
View PDFchevron_right
Inhibition of release of arachidonic acid by monodansylcadaverine during activation of human platelets by collagen
Hwa-Jin Park
Agricultural and Biological Chemistry, 1986
View PDFchevron_right
Effect of some cyclooxygenase inhibitors on the increase in guanosine 3′:5′-cyclic monophosphate induced by NO-donors in human whole platelets
Enrica Cecchi
British Journal of Pharmacology, 1998
View PDFchevron_right
Aggregation and/or oxygenated products of arachidonic acid are not required for collagen-induced deacylation of phosphatidylcholine in human platelets
L. A . Piché
The Biochemical journal, 1989
View PDFchevron_right
Effects of a trans isomer of arachidonic acid on rat platelet aggregation and eicosanoid production
jean-louis sebedio
The Journal of Lipid Research
View PDFchevron_right
Arachidonic Acid Metabolism in Endothelial Cells and Platelets
Nazmul Islam
Annals of The New York Academy of Sciences, 1982
View PDFchevron_right
Effect of GSH depletion by 1-chloro-2,4-dinitrobenzene on human platelet aggregation, arachidonic acid oxidative metabolism and cytoskeletal proteins
GianPiero Pescarmona
Thrombosis Research, 1985
View PDFchevron_right
12(S)-Hydroperoxy-eicosatetraenoic acid increases arachidonic acid availability in collagen-primed platelets
Michel Lagarde
Journal of Lipid Research
View PDFchevron_right
Effect of eicosatetraenyl (3-aminopropyl) phosphonate (URI-73A) on platelet aggregation and arachidonic acid metabolism
Raffaele Landolfi
Prostaglandins, …, 1983
View PDFchevron_right
Modulation of platelet function by reactive oxygen metabolites
Giuseppe Ambrosio
1994
View PDFchevron_right
Aspirin enhances the sensitivity of human platelet 12-lipoxygenase to inhibition by 15-hete, an endogenous regulator
Jack Vanderhoek
Prostaglandins, Leukotrienes and Medicine, 1985
View PDFchevron_right
Comparison of the in vitro effect of eicosapentaenoic acid (EPA)-derived lipoxygenase metabolites on human platelet function with those of arachidonic acid
Mitsuko Takenaga
Thrombosis Research, 1986
View PDFchevron_right
Stronger inhibition by nonsteroid anti-inflammatory drugs of cyclooxygenase-1 in endothelial cells than platelets offers an explanation for increased risk of thrombotic events
John Pepper
The FASEB Journal, 2006
View PDFchevron_right
In vitro effects of aspirin and non steroidal anti-inflammatory drugs on the formation of 12-hydroxyeicosatetraenoic acid by platelets
A. Eynard
Prostaglandins, Leukotrienes and Medicine, 1986
View PDFchevron_right